£12.5M
The seed round was led by BGF with participation from F-Prime Capital, Kindred Capital, and Jonathan Milner.

Shift Bioscience uses generative artificial intelligence models to understand how gene activation can reverse the aging process.
Shift Bioscience is a biotechnology company based in Cambridge that uses generative artificial intelligence models to understand how gene activation can reverse the aging process.
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Cash, assets and headcount from Shift Bioscience's latest Companies House filing — with year-on-year movement, free with a Winfred account.
The seed round was led by BGF with participation from F-Prime Capital, Kindred Capital, and Jonathan Milner.